3 hours PROCEPT BioRobotics (NASDAQ:PRCT) Stock Rating Reaffirmed by Piper Sandler MarketBeat
Piper Sandler reaffirmed an “overweight” rating and set a $75.00 price objective on shares of PROCEPT BioRobotics in a research report on Tuesday.
Piper Sandler reaffirmed an “overweight” rating and set a $75.00 price objective on shares of PROCEPT BioRobotics in a research report on Tuesday.